Literature DB >> 20098447

Diabetes: Treatment of gestational diabetes reduces obstetric morbidity.

Chloe A Zera1, Ellen W Seely.   

Abstract

Should women with gestational diabetes mellitus be treated to minimize both fetal and maternal complications? Although unanswered questions remain about the long-term benefits, the findings of a large, multicenter,randomized controlled trial suggest that treatment of gestational diabetes mellitus decreases perinatal complications.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20098447     DOI： 10.1038/nrendo.2009.265

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  8 in total

1.  Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus.

Authors:  Boyd E Metzger; Thomas A Buchanan; Donald R Coustan; Alberto de Leiva; David B Dunger; David R Hadden; Moshe Hod; John L Kitzmiller; Siri L Kjos; Jeremy N Oats; David J Pettitt; David A Sacks; Christos Zoupas
Journal:  Diabetes Care       Date:  2007-07       Impact factor: 19.112

2.  Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

Authors:  Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2005-06-12       Impact factor: 91.245

3.  ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes.

Authors: 
Journal:  Obstet Gynecol       Date:  2001-09       Impact factor: 7.661

Review 4.  Outcomes of maternal weight gain.

Authors:  Meera Viswanathan; Anna Maria Siega-Riz; Merry K Moos; Andrea Deierlein; Sunni Mumford; Julie Knaack; Patricia Thieda; Linda J Lux; Kathleen N Lohr
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2008-05

5.  Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-05-20       Impact factor: 25.391

6.  Hyperglycemia and adverse pregnancy outcomes.

Authors:  Boyd E Metzger; Lynn P Lowe; Alan R Dyer; Elisabeth R Trimble; Udom Chaovarindr; Donald R Coustan; David R Hadden; David R McCance; Moshe Hod; Harold David McIntyre; Jeremy J N Oats; Bengt Persson; Michael S Rogers; David A Sacks
Journal:  N Engl J Med       Date:  2008-05-08       Impact factor: 91.245

7.  Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators.

Authors:  C D Naylor; M Sermer; E Chen; K Sykora
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

8.  A multicenter, randomized trial of treatment for mild gestational diabetes.

Authors:  Mark B Landon; Catherine Y Spong; Elizabeth Thom; Marshall W Carpenter; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Kristine Y Lain; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa; Garland B Anderson
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245
  8 in total
  2 in total

1.  Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) - protocol for prospective cohort study.

Authors:  D Bogdanet; P M O'Shea; J Halperin; F Dunne
Journal:  BMC Pregnancy Childbirth       Date:  2020-07-18       Impact factor: 3.007

2.  Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol.

Authors:  Chloe Andrews; Michelle Toth-Castillo; Huseyin Aktas; Miguel-Angel Luque Fernandez; Steven Koon Wong; Sarbattama Sen; Jose Halperin
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 3.006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.